stoxline Quote Chart Rank Option Currency Glossary
  
(VTN)
  0 (0%)    09-27 09:28
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:52:27 PM
Short term     
Mid term     
Targets 6-month :  12.81 1-year :  14.96
Resists First :  10.97 Second :  12.81
Pivot price 10.73
Supports First :  10.37 Second :  10
MAs MA(5) :  10.84 MA(20) :  10.58
MA(100) :  10.33 MA(250) :  10.6
MACD MACD :  0.1 Signal :  0.1
%K %D K(14,3) :  79.6 D(3) :  84.1
RSI RSI(14): 69.5
52-week High :  11.65 Low :  9.48
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ VTN ] has closed below upper band by 38.0%. Bollinger Bands are 33.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.91 - 10.96 10.96 - 11.01
Low: 10.68 - 10.74 10.74 - 10.8
Close: 10.72 - 10.81 10.81 - 10.9
Company Description

Headline News

Mon, 11 Aug 2025
Commercial vehicle testing centre in Wicklow to close after 35 years in business - The Irish Independent

Mon, 12 May 2025
Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy - Frontiers

Wed, 07 May 2025
Visit of Mother Chiara Cazzuola to the VTN Province - Istituto Figlie di Maria Ausiliatrice

Wed, 05 Mar 2025
Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease - ScienceDirect.com

Thu, 20 Feb 2025
VOTTUN - ICO Drops

Fri, 15 Nov 2024
Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients - Journal of Translational Medicine

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 15 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 11.6 (%)
Shares Short 46 (K)
Shares Short P.Month 112 (K)
Stock Financials
EPS 0.28
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 11.67
Profit Margin 39 %
Operating Margin 85.7 %
Return on Assets (ttm) 2.5 %
Return on Equity (ttm) 2.8 %
Qtrly Rev. Growth -10.2 %
Gross Profit (p.s.) 1.02
Sales Per Share 1.02
EBITDA (p.s.) 0
Qtrly Earnings Growth -92.4 %
Operating Cash Flow 112 (M)
Levered Free Cash Flow 4 (M)
Stock Valuations
PE Ratio 37.27
PEG Ratio 0
Price to Book value 0.92
Price to Sales 10.52
Price to Cash Flow 1.4
Stock Dividends
Dividend 0.07
Forward Dividend 0
Dividend Yield 0.6%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android